Facebook
Instagram
X
Vimeo
Youtube
Sign in
ACG Home
World News
U.S. News
Local
All Post
Political
Politics
Wash. DC
Republicans
Democrats
Opinion
Activism
Money
Finance
ACG Sports
Sports
Tech, Devices
Tech & Gadgets
Business
Science
Lifestyle
Fashion
Family
Health
Food and Drink
Ecology
Obits, Deaths
TV, Media
Entertainment
Celebrity
Music Ent.
ACG Local Music
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Privacy Policy
Password recovery
Recover your password
your email
Search
Wednesday, November 18, 2026
Facebook
Instagram
X
ACG Home
World News
U.S. News
Local
All Post
Political
Politics
Wash. DC
Republicans
Democrats
Opinion
Activism
Money
Finance
ACG Sports
Sports
Tech, Devices
Tech & Gadgets
Business
Science
Lifestyle
Fashion
Family
Health
Food and Drink
Ecology
Obits, Deaths
TV, Media
Entertainment
Celebrity
Music Ent.
ACG Local Music
Search
Tags
Therapeutics
Tag:
Therapeutics
Money
Viking Therapeutics Initiates Pivotal Phase 3 Trial: Here’s Why Investors Have Reason for Optimism After a Disappointing Phase 2
A C Gazette
-
October 20, 2026
0
Finance
Viking Therapeutics Stock Soars 36% on Weight-Loss Drug Data. Why It’s Not Too Late to Buy the Stock.
A C Gazette
-
September 30, 2026
0
Finance
How Much Could $1,000 Invested in Viking Therapeutics Be Worth by 2030?
A C Gazette
-
July 5, 2026
0
Finance
Don’t Buy Viking Therapeutics Stock Until You Read This
A C Gazette
-
May 26, 2026
0
Finance
Dyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares
A C Gazette
-
May 19, 2026
0
Finance
What’s the Next Big Thing After GLP-1 Drugs? CRISPR Therapeutics May Have the Answer.
A C Gazette
-
April 30, 2026
0
Finance
CIBRA Capital Makes a Big Merger Arbitrage Bet On Amicus Therapeutics (FOLD)
A C Gazette
-
April 25, 2026
0
Finance
Got $5,000? Viking Therapeutics Might Be a Weight‑Loss Drug Moon Shot in the Making.
A C Gazette
-
February 24, 2026
0
Finance
Protagonist Therapeutics Chief Medical Officer Sells PTGX 9,514 Shares for $784K to Cover Taxes
A C Gazette
-
February 1, 2026
0
Finance
Sionna Therapeutics Chief Legal Officer Caps Off Strong 2025 with Sale of Over 10,000 Shares
A C Gazette
-
January 13, 2026
0
1
2
3
...
6
Page 1 of 6
Most Read
The toughest offseason arbitration decision for all 30 MLB teams
November 18, 2026
Brewers Add No. 10 Prospect Williams, Five Others to 40-Man Roster
November 18, 2026
Rocket Companies: 3 Key Takeaways for Long-Term Investors
November 18, 2026
Startup Armed With GPT-6 Cyber Finds Major Java Vulnerability
November 18, 2026